This resolution advocates for the designation of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month." The primary goal is to increase public understanding and recognition of these two distinct, rare, and rapidly progressing neurodegenerative disorders, often referred to as PSP and CBD. PSP and CBD affect multiple brain areas, causing complex symptoms including difficulties with movement, balance, speech, and cognition, and are frequently misdiagnosed. Currently, there are no disease-modifying treatments, and individuals typically face a short life expectancy after symptom onset, placing a significant burden on patients and their caregivers. The resolution emphasizes the critical need for additional research to understand the diseases better, develop effective treatments, and ultimately find cures. It also seeks to bolster support services and education to improve the quality of life for those affected, while recognizing the strength and resilience of the patient and caregiver communities.